Kawasaki disease: Guidelines of Italian Society of Pediatrics, part II - Treatment of resistant forms and cardiovascular complications, follow-up, lifestyle and prevention of cardiovascular risks
- Autori: Marchesi, Alessandra*; Tarissi De Jacobis, Isabella; Rigante, Donato; Rimini, Alessandro; Malorni, Walter; Corsello, Giovanni; Bossi, Grazia; Buonuomo, Sabrina; Cardinale, Fabio; Cortis, Elisabetta; De Benedetti, Fabrizio; De Zorzi, Andrea; Duse, Marzia; Del Principe, Domenico; Dellepiane, Rosa Maria; D'Isanto, Livio; El Hachem, Maya; Esposito, Susanna; Falcini, Fernanda; Giordano, Ugo; Maggio, Maria Cristina; Mannarino, Savina; Marseglia, Gianluigi; Martino, Silvana; Marucci, Giulia; Massaro, Rossella; Pescosolido, Christian; Pietraforte, Donatella; Pietrogrande, Maria Cristina; Salice, Patrizia; Secinaro, Aurelio; Straface, Elisabetta; Villani, Alberto
- Anno di pubblicazione: 2018
- Tipologia: Articolo in rivista (Articolo in rivista)
- OA Link: http://hdl.handle.net/10447/356567
Abstract
This second part of practical Guidelines related to Kawasaki disease (KD) has the goal of contributing to prompt diagnosis and most appropriate treatment of KD resistant forms and cardiovascular complications, including non-pharmacologic treatments, follow-up, lifestyle and prevention of cardiovascular risks in the long-term through a set of 17 recommendations. Guidelines, however, should not be considered a norm that limits the treatment options of pediatricians and practitioners, as treatment modalities other than those recommended may be required as a result of peculiar medical circumstances, patient's condition, and disease severity or individual complications.